(IN BRIEF) Roche’s ongoing Phase Ib/IIa Brainshuttle™ AD study of trontinemab shows that 91 percent of participants reach amyloid PET negativity, with ARIA‑E rates under 5 percent. The company has outlined Phase III TRONTIER 1 and 2 trials in early symptomatic Alzheimer’s for 2025, plus a planned … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Alzheimer’s Association International Conference, amyloid plaques, amyloid‑beta monoclonal antibody, ARIA‑E, blood‑based biomarker, blood‑brain barrier, Brainshuttle, centiloids, clinical dementia rating sum of boxes, cognitive decline, diagnostics, early diagnosis, Elecsys pTau217, Levi Garraway, Matt Sause, PET negativity, Phase Ib/IIa, Phase III TRONTIER 1, Phase III TRONTIER 2, preclinical Alzheimer’s, pTau181, pTau217/Ab42 ratio, Roche, sustainability of clinical trials, TRAVELLER, trontinemab
(IN BRIEF) The University of Liverpool has launched the Liverpool Interdisciplinary Neuroscience Centre (LINC), an ambitious collaboration uniting nearly 170 researchers and clinicians from the University, The Walton Centre NHS Foundation Trust, Brain Health Northwest, and global partners. LINC aims … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged Alder Hey Children’s NHS Foundation Trust, brain health, Brain Health Northwest, brain tumours, British Neuroscience Association, chronic pain, David Fairclough, diagnostics, Dr Andy Nicolson, epilepsy, Epilepsy Research Institute, interdisciplinary research, LINC, Liverpool Interdisciplinary Neuroscience Centre, mental health, Mersey Care, neurodegeneration, neurological disorders, neurosurgery, Professor Benedict Michael, Professor Louise Kenny, Psychiatry, Roche Diagnostics UK & Ireland, The Walton Centre NHS Foundation Trust, therapies, University of Liverpool, WHO Global Action Plan
(IN BRIEF) Dr. Alex Baker, Assistant Professor of Chemistry at The University of Warwick, has been named the winner of the 2025 British Science Association’s Physical Sciences and Mathematics Award Lecture. The award recognizes his exceptional research in Neglected Tropical … Read the full press release
Posted in Awards, Business, Education, Financial, Industrial, Investment, Malta, News, Science, Technology, United Kingdom
Tagged academic recognition, Awards, British Science Association, British Science Festival, chemistry, COVID-19, diagnostics, Dr. Alex Baker, leadership, Neglected Tropical Diseases, Physical Sciences and Mathematics Award, Royal Society of Chemistry, science communication, science education, science engagement, snake venoms, STEM Connect Programme, synthetic antibodies, therapeutics, University of Warwick
(IN BRIEF) SGS Belgium NV has been designated as a Notified Body under the EU’s In Vitro Diagnostic Medical Device Regulation (IVDR), expanding Europe’s limited capacity for regulatory assessments. Approved by the European Commission and Belgian authorities, the Antwerp-based facility … Read the full press release
Posted in Belgium, Business, European Union, Financial, Government, Healthcare, Industrial, Investment, Management, News, Switzerland, Technology
Tagged AFMPS, CE compliance, CE marking, diagnostics, EU 2017/746, EU regulatory compliance, European Commission, FAGG, Geofrey De Visscher, in vitro diagnostic medical devices, ISO 13485, IVDR, IVDR certification services, MDR, MDSAP, medical device certification, NANDO database, Notified Body 1639, partnership, patient safety, regulatory affairs, SGS Antwerp, SGS Belgium, UKCA
(IN BRIEF) The EQT Foundation has opened a global call for proposals under its Breakthrough Science grants program, offering grants from €25,000 to €100,000 to researchers focused on addressing critical female health challenges with deeptech solutions. The initiative seeks to … Read the full press release
Posted in Business, Healthcare, Industrial, Investment, Pharma & Biotech, Sweden
Tagged 000, accredited institutions, Autoimmune Disorders, Breakthrough Science, cardiovascular diseases, commercialization, deeptech, diagnostics, endometriosis, EQT Foundation, female health challenges, financial support, global call for proposals, grants program, gynecological conditions, low-resource settings, maternal health, mentorship, Research & Innovation, therapeutics, Women’s Health
(IN BRIEF) The ESC Preventive Cardiology 2025 Congress will be held in Milan from 3 to 5 April 2025 and is organized by the European Association of Preventive Cardiology, part of the ESC. The event will feature over 120 sessions … Read the full press release
Posted in Business, European Union, France, Healthcare, Industrial, Law, Management, News, Pharma & Biotech, Science
Tagged 3 April 2025, 5 April 2025, artificial intelligence, breakthrough interventions, cancer therapy-induced toxicity, cardiovascular disease, data science, diagnostics, digital cardiac rehabilitation, ESC Preventive Cardiology 2025, European Association of Preventive Cardiology, European Society of Cardiology, gender differences, heart health, interactive workshops, Italian Federation of Cardiology, Italian Strategic Plan for Cardiovascular Health, Italy, live cases, Milan, Nicolle Kränkel, Obesity, Pharmacology, press accreditation, press conference, preventive cardiology, primary prevention, public health, rehabilitation, risk estimation tools, secondary prevention, sports cardiology
(IN BRIEF) On 30 January 2025, over 100 healthcare professionals and researchers gathered at Medisch Spectrum Twente for the presentation of the Pioneers in HealthCare (PIHC) vouchers, aimed at fostering innovative projects to enhance healthcare. Ten projects were selected from … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged 3D printing, AI in healthcare, AI model, asthma, Cancer, Deventer Hospital, diagnostics, endometriosis, healthcare collaboration, Healthcare Innovation, heart failure, imaging technology, liver cancer, medical research, Medisch Spectrum Twente, MRI, partnership, patient care, Patients-Like-Me dashboard, personalised care, PIHC Innovation fund, PIHC vouchers, Pioneers in HealthCare, Saxion University of Applied Sciences, Sleep apnea, University of Twente, Ziekenhuisgroep Twente
(IN BRIEF) At the CTAD 2024 congress in Madrid, Roche presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181, demonstrating their effectiveness in diagnosing Alzheimer’s disease. The blood-based test showed a negative predictive value of 96.2% in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Spain, Switzerland, Technology
Tagged Alzheimer, Clinical Trials in Alzheimer’s Disease congress (CTAD) 2024, diagnostics, Elecsys ptau181, Elecsys® Amyloid Plasma Panel, Healthcare, Matt Sause, Roche, Spain
(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech, Technology
Tagged clinical research project, clinical trial, computerized Tomography, diagnostics, DOTA-TATE Positron Emission Tomography, Dr. Harald Hasselmann, Eckert & Ziegler, Ga-68, GalliaPharm®, Gallium-68, Ge-68, Japan, Japanese Pharmaceuticals and Medical Devices Agency, NCT06240741, NEN, neuroendocrine neoplasms, Novartis Pharma K.K., PET, PMDA, radioisotope supply, rare tumors
(IN BRIEF) The European Investment Bank (EIB) has signed a €10 million loan agreement with Polish company SDS Optic Inc. to support the development and commercialization of their innovative cancer detection technology platform, inPROBE®. SDS Optic specializes in diagnostic and … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Pharma & Biotech, Poland, Science, Technology
Tagged advanced photonic technologies, biomedical engineering, breast cancer, breast cancer detection device, cancer detection technology, diagnostics, EIB, immunochemistry, inPROBE®, inPROBE® HER2, InvestEU programme, loan, Marcin Staniszewski, Molecular Biology, monitoring devices, Paolo Gentiloni, photonic biosensing, Prof. Teresa Czerwińska, SDS Optic Inc., single cell resolution immunoassay, The European Investment Bank, Warsaw Stock Exchange
HORIZON-RIA PROJECT GRANTED FOR THE EARLY DETECTION OF SEPSIS AT THE POINT-OF-CARE DISRUPTIVE SOLUTION FOR SEPSIS DIAGNOSIS AT THE POINT OF CARE THAT WILL OFFER MULTIPLEXED (WITHIN A SINGLE TEST) (IN BRIEF)The AMBROSIA project has been granted under the call … Read the full press release
Posted in Czech Republic, Education, European Union, France, Greece, Healthcare, Ireland, Netherlands, News, Pharma & Biotech, Science, Spain, Switzerland, Technology, United Kingdom
Tagged AMBROSIA, Argotech, Aristotle University of Thessaloniki, Biopix DNA Technology P.C., Catalan Institute of Nanoscience and Nanotechnology, diagnostics, Dr. Alexandros Pantazis, HORIZON-RIA, intelligent sepsis diagnosis, Ligentec, Microfluidics, microLIQUID, nucleic acids, Optical Sensor, PoC, PoC sepsis diagnostic unit, Point of Care, Prof. Nikos Pleros, SEPSIS, SMART PHOTONICS BV, University of Bourgogne, University of Ioannina, University of Southampton, Vall d'Hebron Research Institute, X-Celeprint
(IN BRIEF) Carus Animal Health and UK medical technology company Attomarker have announced a strategic partnership to develop and commercialize a rapid point of care diagnostic device and multiplex assays for animals. The collaboration will use Attomarker’s Covid Antibody Immunity … Read the full press release
Posted in Healthcare, Management, News, Technology, United Kingdom
Tagged Andrew Shaw, Animal Health, Attomarker, Carus Animal Health, diagnostics, Neil Gow, partnership, Ron Long, University of Exeter
(PRESS RELEASE) PARIS AND MONTPELLIER, 30-Mar-2022 — /EuropaWire/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, European Union, France, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged Alcediag, Alcen, Alexandra Prieux, artificial-intelligence, biomarkers, bipolar, bipolar disorder, blood test, Capital Region of Denmark, depression, diagnostics, EDIT-B Consortium, EIT health, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences, Hospital Clínic de Barcelona, IVD, Jean Marc Bourez, Maurizio Ferrari, mental health, neuropsychiatry, Parc Sanitari Sant Joan de Déu, precision medicine, precision psychiatry, ProductLife Group, Prof. Eduard Vieta, psychiatric disorders, Psychiatry, RNA editing, Synlab, World Bipolar Day
People with moderate or mild haemophilia A have significant unmet clinical needs, as this population may not use preventative treatments due to missed or delayed diagnoses of bleeding episodes and a lack of treatment guidelines1,2 New data indicate that Hemlibra has a favourable safety profile in … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged American Society of Hematology, ASH, bleeding, blood clotting, blood disease, Chugai, Chugai Pharmaceutical, diagnostics, emicizumab, Genentech, haemophilia, Haemophilia A, HAVEN 6, Hemlibra®, Levi Garraway, pharmaceuticals, pharmacodynamics, pharmacokinetics, phase III HAVEN 6 study, prophylactic, Roche
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged advance sequencing technologies, AVENIO Edge System, diagnostic solutions, diagnostics, In Vitro Diagnostics, integrated sequencing, IVD, next-generation sequencing, NGS, Roche, sequencing library preparation, Thomas Schinecker
(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release
Posted in Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged appointment, Assay technologies, Audit Committee, Bioinformatics, biomolecules, diagnostics, DNA, Dr. Toralf Haag, Lawrence Rosen, life sciences, Lonza Group AG, Molecular Diagnostics, QIAGEN, RNA, Sample to Insight, Supervisory Board, Thyssen Handelsunion AG, University of Augsburg, University of Kiel, Voith GmbH & Co. KGaA
LIVERPOOL, 02-Sep-2016 — /EuropaWire/ — A researcher from the University of Liverpool’s Institute of Ageing and Chronic Disease, has published a paper about the challenges faced in introducing new devices and diagnostics into health services. Dr Paul Knox, Reader, Eye and … Read the full press release
Posted in Education, Healthcare, Technology, United Kingdom
Tagged diagnostics, Dr Paul Knox, health services, University of Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?